United States · FDA National Drug Code directory
NAPROXEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-4006_1d7a3c9a-73d5-5360-e063-6394a90aa3e6
- Product NDC
- 68071-4006
- Form
- TABLET
- Composition / generic term
- NAPROXEN
- Labeler
- NuCare Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160706
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (68071-4006-1) · 68071-4006-1
- 20 TABLET in 1 BOTTLE (68071-4006-2) · 68071-4006-2
- 30 TABLET in 1 BOTTLE (68071-4006-3) · 68071-4006-3
- 40 TABLET in 1 BOTTLE (68071-4006-4) · 68071-4006-4
- 15 TABLET in 1 BOTTLE (68071-4006-5) · 68071-4006-5
- 60 TABLET in 1 BOTTLE (68071-4006-6) · 68071-4006-6
- 14 TABLET in 1 BOTTLE (68071-4006-7) · 68071-4006-7
- 90 TABLET in 1 BOTTLE (68071-4006-9) · 68071-4006-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →